Sign in
4

Changes in Ownership

Gain Therapeutics, Inc. Filed Acc 0001415889-22-005798

CHIEF EXECUTIVE OFFICER bought 2,482 shares at $2.58 ($6,404)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
RICHMAN ERIC I CHIEF EXECUTIVE OFFICER 2022-05-25 Purchase +2,482 $2.58 $6,404 217,729 D
Open-market purchases · 2,482 sh · avg $2.58 · $6,404
Loading xslF345X03/form4-05272022_040501.xml…